Skip to main content
PGNY logo

Progyny, Inc.

PGNYNASDAQHealthcareHealthcare Plans

$27.46Today:- (-)1Y +28.72%

As of Oct 15, 2026 close

Market cap
$2.26B
P/E (TTM)
28.68
Forward P/E
20.44
Dividend yield
-
52-week range
$16.10$33.07
Volume (live)
-
Avg. volume (3M)
1.17M

Progyny (PGNY) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Progyny generated $210.19M of operating cash flow and spent $18.41M on capital expenditures. That left free cash flow of $191.78M, up 10.4% from $173.70M a year earlier, or 14.9% of revenue. It repurchased $81.66M of its own shares.

Progyny Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Progyny, Inc. (PGNY) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income58.5254.3462.0430.3665.7746.46-8.570.66-12.45
Depreciation & Amortization4.953.182.281.601.301.912.131.881.56
Deferred Income Tax-8.12-10.463.75-6.62-33.30-37.970.01-1.780.00
Stock Based Compensation131.87128.13122.61100.7533.710.005.063.001.56
Change in Working Capital2.80-11.78-17.42-59.49-51.267.35-19.950.35-1.43
Change in Accounts Receivable-5.12-9.87-21.74-119.30-68.68-35.34-25.34-12.78-2.04
Change in Inventory0.000.000.000.000.000.002.272.581.81
Change in Accounts Payable28.75-30.2716.2447.6917.8425.013.5010.45-0.91
Change in Other Working Capital0.4318.44-11.92-1.020.0417.68-0.380.10-0.28
Other Operating Activities0.435.2415.567.180.0418.4619.78-1.851.29
Net Cash from Operating Activities210.19179.11188.8180.4026.0436.20-1.532.27-9.47
Investing Activities
Capital Expenditures-18.41-5.41-3.64-3.24-2.13-1.04-2.96-0.58-0.61
Acquisitions-9.34-5.300.000.000.000.000.000.000.00
Purchases of Investments-354.96-170.34-429.69-163.33-111.48-103.960.000.000.00
Sales/Maturities of Investments223.70376.84232.81122.71122.3764.970.000.000.00
Other Investing Activities0.000.000.000.000.000.000.202.480.00
Net Cash from Investing Activities-159.01195.79-200.53-43.878.77-40.03-2.761.90-0.61
Financing Activities
Debt Repayment0.000.000.000.000.000.000.00-5.10-3.26
Common Stock Issued1.232.406.134.234.272.6881.220.0715.03
Common Stock Repurchased-81.66-312.280.00-12.09-17.970.00-0.19-3.710.00
Other Financing Activities-18.94-12.00-17.20-12.09-17.97-8.933.51-2.4415.03
Net Cash from Financing Activities-99.36-309.88-11.07-7.86-13.70-6.2584.55-8.7411.77
Summary
Effect of Forex Changes on Cash0.060.000.000.000.000.000.000.000.00
Net Change in Cash-48.1265.02-22.7828.6721.11-10.0880.26-4.561.68
Cash at Beginning of Period162.3197.30120.0891.4170.3180.380.134.693.01
Cash at End of Period114.19162.3197.30120.0891.4170.3180.380.134.69
Free Cash Flow191.78173.70185.1777.1523.9135.17-4.491.69-10.09
Supplemental Disclosures
Income Taxes Paid-40.456.180.130.10----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Progyny Cash Flow

What is Progyny's free cash flow?

Progyny generated free cash flow of $191.78M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $210.19M minus $18.41M of capital expenditures. That was up 10.4% from $173.70M a year earlier. Free cash flow equaled 14.9% of revenue.

How much does Progyny spend on capital expenditures?

Progyny spent $18.41M on capital expenditures in fiscal 2025, compared with $5.41M a year earlier. That equals 8.8% of operating cash flow.

Does Progyny pay dividends or buy back shares?

Yes. In fiscal 2025 Progyny returned $81.66M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition